• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki67 目测评分应用与目测评估和数字图像分析的可靠性及其在激素受体阳性乳腺癌中的预后意义。

Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.

机构信息

Department of Pathology, Tata Medical Center, Newtown, Kolkata, India.

Department of Breast Oncosurgery, Tata Medical Center, Newtown, Kolkata, India.

出版信息

APMIS. 2021 Aug;129(8):489-502. doi: 10.1111/apm.13156. Epub 2021 Jun 24.

DOI:10.1111/apm.13156
PMID:34053140
Abstract

We analysed the reproducibility of Ki67 labelling index (LI) between two scorers using the International Ki67 Working Group (IKWG) global methods on an Android application (APP), correlated the APP and eyeball estimate (EBE) with digital image analysis (DIA) scores and determined the prognostic significance of Ki67LI. Global weighted (GW) and global unweighted (GUW) Ki67 app scores of hormone receptor-positive and HER2 (human epidermal growth factor receptor 2)-negative breast cancer patients were obtained. Reproducibility of Ki67LI between 2 scorers and correlation of APP and EBE scores with DIA scores were performed. The prognostic significance of APP scores and its correlation with other clinico-pathologic variables were evaluated. The intra-class correlation coefficient (ICC) between 2 scorers showed excellent reliability with both GW and GUW methods. ICC between DIA and APP scores was significantly greater than DIA versus EBE. The three categories of APP scores based on median value and cut points of 10%, 18% and 38% were significantly associated with poor DFS. On multivariate analysis, significant association between Ki67LI, tumour size, nodal involvement and DFS was noted. Our study shows that the visual Ki67 scoring app is effective in bringing consistency to KI67LI and APP scores showed significant correlation with DFS.

摘要

我们使用 Android 应用程序(APP)上的国际 Ki67 工作组(IKWG)全球方法分析了两位评分者之间 Ki67 标记指数(LI)的可重复性,将 APP 和眼球估计(EBE)与数字图像分析(DIA)评分相关联,并确定 Ki67LI 的预后意义。获取激素受体阳性和 HER2(人表皮生长因子受体 2)阴性乳腺癌患者的全球加权(GW)和全球非加权(GUW)Ki67 APP 评分。对 2 位评分者之间的 Ki67LI 可重复性以及 APP 和 EBE 评分与 DIA 评分的相关性进行了分析。评估了 APP 评分的预后意义及其与其他临床病理变量的相关性。两种 GW 和 GUW 方法均显示,两位评分者之间的组内相关系数(ICC)具有极好的可靠性。DIA 与 APP 评分之间的 ICC 明显大于 DIA 与 EBE 之间的 ICC。基于中位数和 10%、18%和 38%的截断值的 APP 评分的三个类别与较差的 DFS 显著相关。多变量分析显示,Ki67LI、肿瘤大小、淋巴结受累与 DFS 之间存在显著相关性。我们的研究表明,视觉 Ki67 评分 APP 可有效使 Ki67LI 和 APP 评分趋于一致,并且与 DFS 具有显著相关性。

相似文献

1
Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.Ki67 目测评分应用与目测评估和数字图像分析的可靠性及其在激素受体阳性乳腺癌中的预后意义。
APMIS. 2021 Aug;129(8):489-502. doi: 10.1111/apm.13156. Epub 2021 Jun 24.
2
A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.乳腺癌中Ki67标记指数的视觉评估与自动数字图像分析比较
PLoS One. 2016 Feb 29;11(2):e0150505. doi: 10.1371/journal.pone.0150505. eCollection 2016.
3
The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer.Ki67 困境:探究乳腺癌中用于自动 Ki67 评分的预后截止值和可重复性。
Breast Cancer Res Treat. 2024 Aug;207(1):1-12. doi: 10.1007/s10549-024-07352-4. Epub 2024 May 26.
4
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.基于全组织切片虚拟双重染色的乳腺癌 Ki67 增殖指数的数字图像分析:临床验证和平台间一致性。
Breast Cancer Res Treat. 2018 May;169(1):33-42. doi: 10.1007/s10549-018-4669-2. Epub 2018 Jan 18.
5
The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.利用自动Ki67分析预测早期乳腺癌的Oncotype DX复发风险类别。
PLoS One. 2018 Jan 5;13(1):e0188983. doi: 10.1371/journal.pone.0188983. eCollection 2018.
6
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.在雌激素受体阳性/HER2 阴性已行手术的乳腺癌中,肿瘤浸润淋巴细胞的预后意义可能因 Ki67 表达水平而异。
Breast Cancer. 2019 Nov;26(6):738-747. doi: 10.1007/s12282-019-00977-0. Epub 2019 May 16.
7
A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.一种通过自动化数字图像分析确保和提高乳腺癌组织中 Ki67 标记指数估计准确性的方法。
Breast Cancer Res. 2014;16(2):R35. doi: 10.1186/bcr3639.
8
Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.乳腺癌中自动化 Ki67 评估的预后潜力:不同热点定义与真实全局评分的比较。
Breast Cancer Res Treat. 2020 Aug;183(1):161-175. doi: 10.1007/s10549-020-05752-w. Epub 2020 Jun 22.
9
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group.国际乳腺癌 Ki67 工作组自动 Ki67 评分指南的独立临床验证。
Biomolecules. 2021 Oct 30;11(11):1612. doi: 10.3390/biom11111612.
10
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.PgR表达作为通过Ki67标记指数分类的中度风险ER阳性/HER2阴性乳腺癌患者预后因素的作用。
BMC Cancer. 2017 May 22;17(1):354. doi: 10.1186/s12885-017-3331-4.

引用本文的文献

1
Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.Ki-67 指数与肿瘤分级联合用于分层接受直接手术的胰腺导管腺癌患者。
BMC Surg. 2023 Dec 8;23(1):370. doi: 10.1186/s12893-023-02256-4.
2
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.Ki67 在乳腺癌检测中的应用:加拿大病理学家协会工作组的临时检测建议。
Curr Oncol. 2023 Mar 6;30(3):3079-3090. doi: 10.3390/curroncol30030233.
3
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations.
Ki-67与乳腺癌的演变:过去的观察、当前的方向及未来的考量
Cancers (Basel). 2023 Jan 28;15(3):808. doi: 10.3390/cancers15030808.
4
The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer.ONEST(评估主观测试的观察者需要)在评估乳腺癌中雌激素受体、孕激素受体和 Ki67 分类的可重复性方面的附加价值。
Virchows Arch. 2021 Dec;479(6):1101-1109. doi: 10.1007/s00428-021-03172-9. Epub 2021 Aug 20.